Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2811)	6/1/2010 9:32:28 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

PBTH to ring the opening bell on Thursday. <g> Press Release Source: PROLOR Biotech, Inc. On Tuesday June 1, 2010, 7:30 am NES-ZIONA, Israel, June 1 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that Chief Executive Officer Avri Havron and President Shai Novik will ring the opening bell at the New York Stock Exchange (NYSE) at 9:30 AM ET on Thursday, June 3, 2010. "It is a privilege to celebrate PROLOR's recent listing on the NYSE Amex by ringing the opening bell at the New York Stock Exchange," said Shai Novik, President of PROLOR. "Over the past year, we have made significant progress in advancing PROLOR's pipeline of CTP-enhanced protein therapeutics, which have the potential to address biopharmaceutical markets estimated at more than $25 billion. The positive clinical and preclinical data we have reported reinforce our belief that our technology has the potential to significantly improve a wide range of protein therapeutics currently used by millions of patients. We look forward to announcing progress on a number of important milestones over the coming months."<g> news.moneycentral.msn.com Bernard